Login / Signup

Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy.

Daniel J LandsburgMitchell E HughesAlexa KoikeDavid BondKami J MaddocksLing GuoAllison M WinterBrian T HillSarah L OndrejkaEric D HsiSunita D NastaJakub SvobodaStephen J SchusterAgata M Bogusz
Published in: Blood advances (2020)
Keyphrases